Your institution may have access to this item. Find your institution then sign in to continue.
Title
Management of mTOR Inhibitor Side Effects.
Authors
Creel, Patricia A.
Abstract
Although surgery remains the primary curative treatment for renal cell carcinoma (RCC), systemic therapy also is indicated in the advanced disease setting. This article reviews the role of mammalian target of rapamycin inhibitors in the treatment of metastatic RCC. A case study is presented to illustrate side-effect management issues commonly encountered by oncology nurses in clinical practice.
Publication
Clinical Journal of Oncology Nursing, 2009, Vol 13, p19